New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 16 10:16AM ET
25.17
Dollar change
+0.14
Percentage change
0.56
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings34 Perf Week0.44%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM56.64M Perf Month4.75%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter9.76%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High27.76 -9.33% Perf Half Y1.47%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 34.02% Perf YTD7.61%
Active/Passive Quant Type Tagsmedical Flows% 1M1.27% Volatility0.46% 0.73% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M2.05% ATR (14)0.40 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD8.58% RSI (14)58.91 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.54% Growth/Value SMA201.69% Flows% 3Y Rel Volume0.02 Prev Close25.03
Inverse/Leveraged Market Cap SMA507.53% Flows% 5Y Avg Volume2.63K Price25.17
IPOOct 31, 2024 Option/ShortNo / Yes SMA2004.02% Trades Volume25 Change0.56%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.